Le Lézard
Classified in: Covid-19 virus

Worldwide Bone Growth Stimulators Market to 2026 - Industry Analysis and Forecast - ResearchAndMarkets.com


The "Global Bone Growth Stimulators Market By Product, By Application, By Distribution Channel, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

The Global Bone Growth Stimulators Market size is expected to reach $1.7 billion by 2026, rising at a market growth of 7.1% CAGR during the forecast period. Bone growth stimulator devices are medical devices that accelerate the fracture healing cycle in cases of delay or failure. They improve the normal speed of healing by giving patients electrical shocks. Some of the available bone growth stimulators in the market include bone stimulation tools, bone morphogenetic proteins, and platelet-rich plasma. There are three types of bone stimulation devices, including pulsed electromagnetic field devices, capacitive coupling devices, and combined magnetic field devices.

Increasing cases of chronic conditions such as arthritis and osteoporosis is expected to drive market growth. The susceptibility to fractures rises with age, which means that the increasing geriatric population will also contribute to the growth of the global demand for bone growth stimulators. Demographic factors such as increasing average age and global average life expectancy is expected to also have an effect on the overall growth of the market. Diabetes mellitus hinders the body's normal healing cycle. Growing cases of diabetes along with other medical conditions such as vascular disease, kidney disorders, and obesity is expected to fuel the demand over the forecast timeframe.

With the globally rising infection of Covid-19, the apprehension of the lack of essential life-saving equipment and other vital medical supplies to prevent the spread of this pandemic is also expanding and providing optimum care for the infected. In addition, before pharmacological treatment is established, ventilators serve as a vital treatment preference for COVID-19 patients who may need critical care. In addition, there is an immediate need for rapid acceleration in the manufacturing cycle for a wide range of test kits (antibody tests, self-administration, and others).

Based on Product, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma. Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others. Based on Distribution Channel, the market is segmented into Hospitals & Clinics, Home Care and Others. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

Companies Profiled:

Unique Offerings from the Publisher:

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

2.1 Introduction

2.1.1 Overview

2.1.2 Market Composition and Scenario

2.2 Key Factors Impacting the Market

2.2.1 Market Drivers

2.2.2 Market Restraints

Chapter 3. Global Bone Growth Stimulators Market by Product

3.1 Global Bone Growth Stimulation Devices Market by Region

3.2 Global Bone Morphogenetic Proteins Market by Region

3.3 Global Platelet-Rich Plasma Market by Region

Chapter 4. Global Bone Growth Stimulators Market by Application

4.1 Global Spinal Fusion Surgeries Market by Region

4.2 Global Delayed Union & Nonunion Bone Fractures Market by Region

4.3 Global Oral & Maxillofacial Surgeries Market by Region

4.4 Global Other Application Market by Region

Chapter 5. Global Bone Growth Stimulators Market by Distribution Channel

5.1 Global Hospitals & Clinics Market by Region

5.2 Global Home Care Market by Region

5.3 Global Others Market by Region

Chapter 6. Global Bone Growth Stimulators Market by Region

6.1 North America Bone Growth Stimulators Market

6.2 Europe Bone Growth Stimulators Market

6.3 Asia Pacific Bone Growth Stimulators Market

6.4 LAMEA Bone Growth Stimulators Market

Chapter 7. Company Profiles

7.1 Johnson and Johnson

7.1.1 Company Overview

7.1.2 Financial Analysis

7.1.3 Segmental &Regional Analysis

7.1.4 Research & Development Expenses

7.1.5 Recent strategies and developments:

7.1.5.1 Acquisition and Mergers:

7.1.5.2 Product Launches and Product Expansions:

For more information about this report visit https://www.researchandmarkets.com/r/vo8ihz

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


These press releases may also interest you

at 05:05
Sonida Senior Living, Inc. (the "Company," "we," "our," or "us") , a leading owner-operator and investor in communities and services for seniors, today announced its results for the first quarter ended March 31, 2024. "We achieved strong...

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:00
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

9 mai 2024
Star Asia Group is pleased to announce that it has entered into a share transfer agreement with Minacia Co., Ltd. ("Minacia") on April 26, 2024, to acquire 100% of the shares of Minacia. 1? Reason for Share Acquisition Star Asia Group believes that...

9 mai 2024
In the Company's announcement dated May 9, 2024, the 2023 comparative year EBITDA was corrected from $33.2 million to $44.8 million. The complete correct press release follows: Q1 2024 Financial Highlights(1): Revenues of $602.5 millionGross Margin...

9 mai 2024
Afya Limited ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024)....



News published on and distributed by: